Clinical trial
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy…
NCT00258440 · OHSU Knight Cancer Institute, Other · Terminated
Key facts
| NCT number | NCT00258440 |
|---|---|
| Title | Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer |
| Official title | A Pilot Trial of Extended Interval Dosing of Epoetin Alfa (Procrit®) for the Treatment of Anemia in Oncology Patients |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | Ortho Biotech, Inc. Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Anemia, Fatigue, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | Weekly procrit dosing, Interval Dosing |
| Enrollment | 7 |
| Start date | May 1, 2003 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Nov 24, 2005 |
| Last update posted | May 9, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: